Clinical Trials Browser

INDUSTRY × Prostatic Neoplasms × pertuzumab × Clear all

NCT02480010 2015-09-18

A Study of Pertuzumab in Participants With Prostate Cancer

Phase 2 Terminated

68 enrolled 18 charts

Prostatic Neoplasms

NCT00058539 2015-06-23

Safety and Efficacy Study of Pertuzumab to Treat Castration-Resistant Prostate Cancer

Phase 2 Completed

42 enrolled 10 charts

Prostatic Neoplasms